The organic revenue decline of 4.1% and significant margin compression across both segments indicate the 'Revival' program has not yet stabilized the business. With adjusted net leverage at 3.3x and free cash flow halved, the stock is likely to trade down. Monitor the next quarter for any signs of organic growth stabilization or further guidance changes.
Price Chart
Executive Summary
Avantor reported Q1 2026 results with net sales flat YoY at $1.58B, GAAP EPS of $0.06, and adjusted EPS of $0.17. Revenue was flat on a reported basis but declined 4.1% organically. Net income fell to $43.3M from $64.5M, and adjusted EBITDA margin contracted to 13.9% from 17.0%. The company reaffirmed its FY 2026 guidance, but the underlying trends show continued organic revenue decline and margin compression, making this a bearish report.
Key Financial Metrics
Key Facts
- Net sales of $1,581.4M, flat YoY on a reported basis but down 4.1% organically
- GAAP diluted EPS of $0.06 vs $0.09 in Q1 2025; adjusted EPS of $0.17 vs $0.23
- Net income decreased to $43.3M from $64.5M; net income margin fell to 2.7% from 4.1%
- Adjusted EBITDA of $219.4M, down from $269.5M; margin contracted to 13.9% from 17.0%
- Operating cash flow dropped to $58.7M from $109.3M; free cash flow fell to $25.2M from $82.1M
- VWR Distribution Services segment: sales down 0.4% reported, down 4.8% organically; Adj. Op. Income margin fell to 9.2% from 12.8%
- Bioscience Medtech Products: sales up 1.2% reported, down 2.0% organically; Adj. Op. Income margin fell to 23.8% from 26.9%
- Company reaffirmed FY 2026 guidance provided on February 11, 2026
Financial Impact
Adjusted EBITDA down $50.1M YoY; operating cash flow down $50.6M; free cash flow down $56.9M
Risk Factors
- Continued organic revenue decline in both segments
- Further margin compression from restructuring costs and competitive pressures
- Elevated leverage (3.3x adjusted net) limits financial flexibility
- Restructuring execution risk — the 'Revival' program may not deliver expected results
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-028078 |
| Document: avtr-20260429.htm | 0001628280-26-028078 |
| Document: 0001628280-26-028078-index-headers.html | 0001628280-26-028078 |
| Document: 0001628280-26-028078-index.html | 0001628280-26-028078 |
| Document: 0001628280-26-028078.txt | 0001628280-26-028078 |
| 8-K Data (Synthetic) | 0001628280-26-028078 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | Institutional Cluster | $17.15 | awaiting T+60 | — | $17.29 (+0.82%) |
Oct 1, 2026 25d ago | Press Release | $15.03 | awaiting T+60 | — | $17.29 (+15.04%) |
Sep 21, 2026 5w ago | 8-K | $15.10 | awaiting T+60 | — | $17.29 (+14.50%) |
Sep 21, 2026 5w ago | 8-K | $15.10 | awaiting T+60 | — | $17.29 (+14.50%) |
Jul 22, 2026 13w ago | Institutional Cluster | $11.35 $16.09 | ▼ −41.76% | ▼ −37.21% | $17.29 (−52.33%) |
Jul 17, 2026 14w ago | Institutional Cluster | $11.07 $15.49 | ▲ +39.93% | ▲ +35.24% | $17.29 (+56.19%) |
May 1, 2026 25w ago | Insider Cluster | $7.93 $11.76 | ▲ +48.39% | ▲ +45.83% | $17.29 (+118.17%) |
Apr 29, 2026 25w ago | 8-K | $7.84 $11.35 | ▼ −44.86% | ▼ −41.12% | $17.29 (−120.68%) |
Feb 25, 2026 34w ago | 8-K/A | $9.01 $8.12 | ▼ −9.88% | ▼ −18.05% | $17.29 (+91.90%) |
Feb 25, 2026 34w ago | 8-K/A | $9.01 $8.12 | ▼ −9.88% | ▼ −18.05% | $17.29 (+91.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers